Riverhead Capital Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Riverhead Capital Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-12,120	Closed	-$654K	–	1583
2017 Q4	$654K	Buy	12,120 +2,600	+27%	+$142K	0.03%	562
2017 Q3	$543K	Sell	9,520 -3,007	-24%	-$176K	0.03%	577
2017 Q2	$754K	Buy	12,527 +7,927	+172%	+$451K	0.04%	459
2017 Q1	$250K	Buy	+4,600	New	+$227K	0.01%	712

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Riverhead Capital Management's BIVV Position: Q1 2018 in Review

Riverhead Capital Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 12,120 shares — an estimated $654K sold.

Riverhead Capital Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $754K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Riverhead Capital Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Riverhead Capital Management sold 12,120 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $654K.
Riverhead Capital Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Riverhead Capital Management's Bioverativ Inc. Common Stock position peaked at $754K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Riverhead Capital Management's 13F filing for Q1 2018, filed 8 May 2018.